<DOC>
	<DOCNO>NCT00000378</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness select serotonin re-uptake inhibitor ( SSRI , sertraline ) tricyclic antidepressant ( TCA , nortriptyline ) outpatients age 60 major depression . SSRIs effective treatment major depression . However , also evidence SSRIs may significantly less effective TCAs patient late-life major depression melancholia . Since SSRIs seem easy take TCAs widely prescribe , important determine type antidepressant work best treat patient . Patients assign randomly receive either sertraline ( SSRI ) nortriptyline ( TCA ) 12 week . Patients monitor symptom , side effect , quality life . If patient responds treatment , he/she participate 6-month continuation phase he/she continue receive medication . An individual may eligible study he/she : Has unipolar major depression ( exception ) 60 year old .</brief_summary>
	<brief_title>Antidepressant Treatment Melancholia Late Life</brief_title>
	<detailed_description>To compare efficacy safety select serotonin re-uptake inhibitor ( SSRI , sertraline ) tricyclic antidepressant ( TCA , nortriptyline ) outpatients age 60 meet Diagnostic Statistical Manuel-IV criterion unipolar major depression , exclude patient meet criterion psychotic atypical subtype . To test hypothesis medication condition interact diagnostic subtype ( melancholic v non-melancholic ) determine antidepressant response . To examine role symptom severity alternative diagnostic subtyping contribute pattern . SSRIs effective treatment major depression . However , also evidence SSRIs may significantly less effective TCAs depress patient melancholia . This issue particular concern late-life major depression . SSRIs important safety advantage respect overdose benign cardiovascular profile . Furthermore , SSRIs significant anticholinergic effect , appear well tolerate TCAs . Perhaps important , SSRIs currently prescribe widely medication treatment first choice major depression late life . Therefore , determine SSRIs considerably less effective TCAs treatment melancholia elderly , would significant ramification clinical practice . Randomization sertraline ( SSRI ) nortriptyline ( TCA ) stratify presence absence melancholia . Outcome measure 12-week acute phase include clinician patient rating symptom , side effect , evaluation health-related quality life ( HRQOL ) . At end acute treatment phase , patient meet criteria clinical response participate 6-month continuation phase .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Antidepressive Agents , Tricyclic</mesh_term>
	<criteria>Patients must : Unipolar major depression ( per Diagnostic Statistical ManuelIV criterion ) without melancholia . Patients follow symptoms condition exclude : Psychotic atypical subtype unipolar major depression .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Aged</keyword>
	<keyword>Antidepressive Agents , Tricyclic</keyword>
	<keyword>Depression</keyword>
	<keyword>Female</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>Middle Age</keyword>
	<keyword>Nortriptyline</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Serotonin Uptake Inhibitors</keyword>
	<keyword>Antidepressive Agents , Tricyclic -- *therapeutic use</keyword>
	<keyword>Antidepressive Agents , Tricyclic -- adverse effect</keyword>
	<keyword>Depression -- *drug therapy</keyword>
	<keyword>Nortriptyline -- *therapeutic use</keyword>
	<keyword>Nortriptyline -- adverse effect</keyword>
	<keyword>Sertraline -- *therapeutic use</keyword>
	<keyword>Sertraline -- adverse effect</keyword>
	<keyword>Serotonin Uptake Inhibitors -- *therapeutic use</keyword>
	<keyword>Serotonin Uptake Inhibitors -- adverse effect</keyword>
</DOC>